Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nostics is a medical technology company specializing in rapid, point-of-care diagnostic solutions for infectious diseases. The company utilizes a proprietary platform that combines Surface-Enhanced Raman Spectroscopy (SERS) with advanced artificial intelligence to identify pathogens within minutes, bypassing the need for lengthy lab cultures. Their primary focus is on addressing global health challenges like antimicrobial resistance by enabling immediate, targeted treatment for conditions such as urinary tract infections. Headquartered in Amsterdam, Nostics aims to decentralize high-quality diagnostics to improve patient outcomes and healthcare efficiency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nostics.